RIGAMONTI, ANTONELLO EMILIO
RIGAMONTI, ANTONELLO EMILIO
Dipartimento di Scienze Cliniche e di Comunità
A follow-up of GH-dependent biomarkers during a 6-month period of the sporting season of male and female athletes
2006 A. Sartorio, M. Jubeau, F. Agosti, N. Marazzi, A. Rigamonti, E.E. Müller
A Metabolomics-Based Investigation of the Effects of a Short-Term Body Weight Reduction Program in a Cohort of Adolescents with Obesity: A Prospective Interventional Clinical Study
2023 A.E. Rigamonti, G. Frigerio, D. Caroli, A. De Col, S.G. Cella, A. Sartorio, S. Fustinoni
Abuse of recombinant human growth hormone: studies in two different dog models
2004 A.E. Rigamonti, D. Scanniffio, S.M. Bonomo, S.G. Cella, A. Sartorio, E.E. Muller
Acute administration of capsaicin increases resting energy expenditure in young obese subjects without affecting energy intake, appetite, and circulating levels of orexigenic/anorexigenic peptides
2018 A.E. Rigamonti, C. Casnici, O. Marelli, A. De Col, S. Tamini, E. Lucchetti, G. Tringali, R. De Micheli, L. Abbruzzese, M. Bortolotti, S.G. Cella, A. Sartorio
An algorithm to identify patients with type 2 diabetes mellitus among undocumented migrants using data on drugs dispensation by charities: A pilot study
2018 G. Fiorini, C. Cerri, S. Bini, A.E. Rigamonti, N. Marazzi, A. Sartorio, S.G. Cella
Angiotensin II type 1 receptor antagonism improves endothelial vasodilator function in L-NAME-induced hypertensive rats by a kinin-dependent mechanism
2006 V. De Gennaro Colonna, S. Fioretti, A. Rigamonti, S. Bonomo, B. Manfredi, E. Müller, F. Berti, G. Rossoni
Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats
2005 V. De Gennaro Colonna, A. Rigamonti, S. Fioretti, S. Bonomo, B. Manfredi, P. Ferrario, M. Bianchi, F. Berti, E.E. Muller, G. Rossoni
Anorexigenic postprandial responses of PYY and GLP1 to slow ice cream consumption : preservation in obese adolescents, but not in obese adults
2013 A.E. Rigamonti, F. Agosti, E. Compri, M. Giunta, N. Marazzi, E.E. Müller, S.G. Cella, A. Sartorio
Anticipatory and consummatory effects of (hedonic) chocolate intake are associated with increased circulating levels of the orexigenic peptide ghrelin and endocannabinoids in obese adults
2015 A.E. Rigamonti, F. Piscitelli, T. Aveta, F. Agosti, A.D. Col, S. Bini, S.G. Cella, V.D. Marzo, A. Sartorio
Aspects of the central nervous drive to growth hormone secretion during aging
1997 E. Müller, S. Cella, A. Rigamonti, E. Degli Uberti, M. Ambrosio, D. Cocchi
Basi dell’efficacia clinica del D-mannosio e dell’estratto di melagrana nelle infezioni urinarie
2014 A.E. Rigamonti
Ceramide Risk Score in the Evaluation of Metabolic Syndrome: An Additional or Substitutive Biochemical Marker in the Clinical Practice?
2023 A.E. Rigamonti, M.V. DEI CAS, D. Caroli, A. Bondesan, S.G. Cella, R. Paroni, A. Sartorio
Changes in DNA Methylation of Clock Genes in Obese Adolescents after a Short-Term Body Weight Reduction Program: A Possible Metabolic and Endocrine Chrono-Resynchronization
2022 A.E. Rigamonti, V. Bollati, C. Favero, B. Albetti, D. Caroli, A. De Col, S.G. Cella, A. Sartorio
Changes in plasma levels of ghrelin, leptin, and other hormonal and metabolic parameters following standardized breakfast, lunch, and physical exercise before and after a multidisciplinary weight-reduction intervention in obese adolescents
2010 A.E. Rigamonti, F. Agosti, A. De Col, N. Marazzi, C.L. Lafortuna, S.G. Cella, E.E. Muller, A. Sartorio
Characterizing non-communicable disease trends in undocumented migrants over a period of 10 years in Italy
2023 G. Fiorini, M. Franchi, G. Pellegrini, A.E. Rigamonti, A. Sartorio, N. Marazzi, G. Corrao, S.G. Cella
Children with Prader-Willi syndrome exhibit more evident meal-induced responses in plasma ghrelin and peptide YY levels than obese and lean children
2010 C. Bizzarri, A.E. Rigamonti, A. Luce, M. Cappa, S.G. Cella, J. Berini, A. Sartorio, E.E. Müller, A. Salvatoni
Chronic intracerebroventricular injection of TLQP-21 prevents high fat diet induced weight gain in fast weight-gaining mice
2009 A. Bartolomucci, E. Bresciani, I. Bulgarelli, A.E. Rigamonti, T. Pascucci, A. Levi, R. Possenti, A. Torsello, V. Locatelli, E.E. Muller, A. Moles
Chronic intracerebroventricular TLQP-21 delivery does not modulate the GH/IGF-1-axis and muscle strength in mice
2007 A. Bartolomucci, A.E. Rigamonti, I. Bulgarelli, A. Torsello, V. Locatelli, F. Pavone, A. Levi, R. Possenti, E.E. Muller, A. Moles
Combination of external load and whole body vibration potentiates the GH-releasing effect of squatting in healthy females
2013 M. Giunta, A.E. Rigamonti, F. Agosti, A. Patrizi, E. Compri, M. Cardinale, A. Sartorio
Combined evaluation of resting IGF-I, N-terminal propeptide of type III procollagen (PIIINP) and C-terminal cross-linked telopeptide of type I collagen (ICTP) levels might be useful for detecting inappropriate GH administration in athletes: a preliminary
2004 A. Sartorio, F. Agosti, N. Marazzi, N.A. Maffiuletti, S.G. Cella, A. Rigamonti, L. Guidetti, L. Di Luigi, E. Muller